Oncotherapeutica, Inc.

UEI
Y26BK7DKJS89
CAGE
79YD5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Prostate cancer selective radioactive prodrug HHSN261201600016C National Cancer Institute (NIH) $298,882

Quick answers

Is Oncotherapeutica, Inc. registered in SAM.gov?

Oncotherapeutica, Inc.'s SAM.gov registration expired on March 4, 2026.

What is Oncotherapeutica, Inc.'s most recent federal award?

Oncotherapeutica, Inc.'s most recent federal contract award is Prostate cancer selective radioactive prodrug (HHSN261201600016C), from National Cancer Institute (NIH), on September 19, 2016.

On GovTribe

See Oncotherapeutica, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login